Clinical Edge Journal Scan

Breast cancer: Routine scans can identify heart disease


 

Key clinical point: The presence and extent of coronary artery calcium (CAC), as automatically quantified on routinely performed computed tomography scans, are associated with cardiovascular and coronary artery diseases.

Major finding: The risk for cardiovascular disease increased with a higher CAC score (adjusted hazard ratio, 1.8, 2.1, and 3.4 for CAC scores 11-100, 101-400, and greater than 400, respectively). The risk for coronary artery disease also increased with an increase in CAC score (adjusted hazard ratio, 2.8, 4.3, and 7.8 for CAC scores 11-100, 101-400, and greater than 400, respectively).

Study details: A multicenter cohort study of 15,915 patients with breast cancer who received radiotherapy between 2005 and 2016. The CAC scores were automatically extracted from computed tomography scans using a deep learning algorithm.

Disclosure: This study was funded by the Dutch Cancer Society. The authors received grants, lecture fees, and research support from various sources. Dr. Leiner and Dr. Isgum owned shares of Quantib-U BV and/or a patent with royalties planned. No other conflicts of interest were reported.

Source: Gal R et al. JAMA Oncol. 2021 May 6. doi: 10.1001/jamaoncol.2021.1144.

Recommended Reading

Optimal Treatment for HR+/HER2- Breast Cancer Patients With Visceral Metastasis
MDedge Hematology and Oncology
Breast cancer survivors have specific gynecological needs
MDedge Hematology and Oncology
BERENICE: Further evidence of heart safety of dual HER2 blockade
MDedge Hematology and Oncology
No survival dip with neoadjuvant letrozole-palbociclib in NeoPAL study
MDedge Hematology and Oncology
GELATO trial: Chemoimmunotherapy may help in metastatic invasive lobular breast cancer
MDedge Hematology and Oncology
New targeted treatments are major advances for HER2-positive breast cancer
MDedge Hematology and Oncology
Endocrine therapy benefits in premenopausal breast cancer differ by molecular risk
MDedge Hematology and Oncology
Trastuzumab deruxtecan-related lung disease in MBC patients can occur anytime in first year
MDedge Hematology and Oncology
Clinical Edge Journal Scan Commentary: Breast Cancer June 2021
MDedge Hematology and Oncology
Breast-conserving surgery tops mastectomy
MDedge Hematology and Oncology